The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Three new studies to be presented at the upcoming European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference at the end of the month demonstrate benefits of the antiviral molnupiravir against COVID-19 infections, including evidence that Merck's pill reduces symptoms of the SARS-CoV-2 virus by day 3 of administration.
Early treatment with ivermectin didn't prevent hospitalization for COVID-19.
Among the 1,185 hospitalized kids and teens in the study, 88% were unvaccinated.
Also, 44% reported feeling persistently sad or hopeless, and 55% noted domestic emotional abuse by an adult.
The WHO updates its strategic pandemic plan and calls for better genomic surveillance of pathogens.
Also, Biden warns that a lack of funds means booster shots may not be free in the fall.
Among 91 COVID-19 pneumonia survivors in Austria, 54% had lung abnormalities on computed tomography (CT) imaging 1 year after symptom onset, suggests an observational study yesterday in Radiology.
The CDC also recommends an additional booster dose for at-risk groups.
Black patients had higher rates of hospital or ICU stay, ventilation, and death.
Results of a new survey of 436 Americans with long COVID reveal that the condition is significantly associated with poorer long-term health status, worse quality of life, and psychological distress. The results were published yesterday in Influenza and Other Respiratory Viruses.
